Neurolief Secures $6M Investment to Expand Brain Neuromodulation Therapy Post FDA Approval Neurolief announces a $6 million investment to broaden access to its Proliv™Rx brain neuromodulation therapy, post FDA approval, for depression patients.

Neurolief Secures $6M Investment to Expand Brain Neuromodulation Therapy Post FDA Approval #USA #Coral_Springs #Neurolief #BrainsWay #ProlivRx

The Depression Clinic in beautiful #stcharles
#stcharlesmo
#Missouri uses #BrainsWay Deep TMS to target the brain centers that regulate mood. #Depression #Anxiety #PTSD & other #mentalillness
Get remission w/o meds.
Thedepressionclinicstcharles.com
636-946-7246 (PAIN)

Neurolief and BrainsWay Unite to Launch Innovative Proliv™Rx for Depression Treatment Neurolief is set to transform depression treatment with its new at-home therapy, Proliv™Rx, thanks to strategic backing from BrainsWay.

Neurolief and BrainsWay Unite to Launch Innovative Proliv™Rx for Depression Treatment #USA #Coral_Springs #Neurolief #Proliv™Rx #BrainsWay

BrainsWay Sponsors Free CME Courses to Advance TMS Education for Mental Health Professionals BrainsWay Ltd. (Nasdaq: BWAY), a global leader in non-invasive brain stimulation therapies, is expanding access to education on transcranial magnetic stimulatio

#BWAY
#BrainsWay sponsors two free CME courses to advance education on TMS therapy, helping mental health professionals expand treatment options for patients.
prismmarketview.com/brainsway-sp...